Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TNA vs GSK✓SelectedUSD · GSKTNA vs GSK performance historyLatest closeAs of-6.63%11/19
Stock and ETF performance explorer

TNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-49.4%
GSK return
+39.6%
Excess return
-89.0%
Maximum drawdown
-80.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.6%-1.6%-5.1%-5.8%
7D-15.0%-4.7%-10.3%-12.8%
30D-14.2%-4.7%-9.5%-11.9%
3M-35.7%-8.8%-27.0%-32.7%
6M-16.6%-4.6%-11.9%-15.2%
YTD+5.4%+1.0%+4.4%+3.2%
1Y+22.0%+6.9%+15.1%+15.8%
3Y+73.9%+52.5%+21.3%+23.4%
5Y-49.4%+40.3%-89.7%-69.8%
All-49.4%+39.6%-89.0%-69.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling